Blog

Paolo Tarantino: Honored to moderate the SABCS 2024 People’s Choice session

Paolo Tarantino/X

Nov 5, 2024, 15:51

Paolo Tarantino: Honored to moderate the SABCS 2024 People’s Choice session

Paolo Tarantino posted on X:

“Honored to moderate the SABCS 2024 People’s Choice session on the future of ADCs

We will review in depth the nuances of ADCs MoA, clinical use, development strategies.

And we will try guessing ADC’s future(s). Make sure not to miss it!

Dec 11, 3.30 pm.”

Erika Hamilton shared this post on X, adding:

“Promises to be an amazing session!”

Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.

Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.